» Articles » PMID: 36554798

HIV Detection and Delayed Diagnosis: A Time Series Analysis in China

Overview
Publisher MDPI
Date 2022 Dec 23
PMID 36554798
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Insufficient HIV detection and late presentation to antiretroviral therapy (ART) pose significant public health challenges. In China, universal access to HIV testing is available now. Under this background, we aim to analyze the trends of HIV detection and the prevalence of delayed HIV diagnosis (DHD) in order to provide evidence for HIV prevention and treatment in China.

Methods: Data of HIV tests in Hangzhou city between 2007 and 2018 were collected from the Chinese National HIV/AIDS Comprehensive Response Information Management System (CRIMS). Descriptive statistics were used to describe the characteristics of HIV testing and detection and the prevalence of DHD among newly diagnosed HIV cases. Non-parametric tests were employed to examine the prevalence of DHD among newly diagnosed HIV cases. Moreover, logistic regression models were employed to explore the influencing factors of DHD.

Results: Testing rates doubled from 14.1% in 2007-2010 to 28.2% in 2016-2018. The total positive rate of HIV tests was 5.3 per 10,000. Preoperative testing was the predominant pathway for HIV tests, accounting for 41.9%, followed by testing for health screening, maternal examination and other patients, accounting for 18.4%, 13.2% and 11.8%, respectively. Meanwhile, the predominant pathway for HIV case detection was also preoperative testing, accounting for 29.1%, followed by testing for other patients, testing at STD clinics and VCT, with the proportions of 18.8%, 15.8% and 13.6%, respectively. MSM (men who have sex with men) contact was the main transmission route, accounting for 55.3%, followed by heterosexual contact, accounting for 41.6%. Overall, DHD occurred in 29.0% of the newly diagnosed cases, and this rate had not improved over the years. A higher prevalence of DHD was found in those diagnosed through a pre-test for receiving blood/products [OR (95%CI): 5.42(2.95-9.97)], detection of other patients [OR (95%CI): 2.08(1.64-2.63)], preoperative testing [OR (95%CI): 1.83(1.44-2.32)] and spouse or sexual partner testing in positive person [OR (95%CI): 1.93(1.34-2.78)] compared with those diagnosed at a VCT clinic. Heterosexuals [OR (95%CI): 1.20(1.06-1.36)] had a higher risk of DHD than MSM. Diagnosis at a CDC [OR (95%CI): 0.68(0.55-0.83)] and community health centers [OR (95%CI): 0.54(0.39-0.75)] had a lower risk of DHD than in hospitals. Older age, males, being single/divorced or widowed and floating population were also associated with DHD.

Conclusions: In China, DHD had not improved in the last 10 years, although HIV testing had been expanded. Therefore, it is important for continued efforts to promote early diagnosis of HIV to prevent transmission, morbidity and early mortality in HIV infection.

Citing Articles

Study on the prediction performance of AIDS monthly incidence in Xinjiang based on time series and deep learning models.

Tang D, Jin Y, Hu X, Lin D, Kapar A, Wang Y BMC Public Health. 2025; 25(1):780.

PMID: 40001115 PMC: 11863473. DOI: 10.1186/s12889-025-21982-3.


Preference for HIV testing among community residents in Yunnan Province, China: results from a discrete choice experiment.

Yang J, Qiu C, Tang R, Dong W, Yao E, Wang H BMC Health Serv Res. 2025; 25(1):216.

PMID: 39920697 PMC: 11803934. DOI: 10.1186/s12913-025-12357-w.


Unveiling trends in late diagnosis among 22,504 people living with HIV in Hunan, China.

Su X, Zhong X, Zhang X, Gao Y, Zou X, Chen X Sci Rep. 2024; 14(1):23165.

PMID: 39369087 PMC: 11455870. DOI: 10.1038/s41598-024-73648-6.


Combining molecular transmission network analysis and spatial epidemiology to reveal HIV-1 transmission pattern among the older people in Nanjing, China.

Xu Y, Jiang T, Jiang L, Shi H, Li X, Qiao M Virol J. 2024; 21(1):218.

PMID: 39278908 PMC: 11404066. DOI: 10.1186/s12985-024-02493-w.


Molecular transmission network analysis of newly diagnosed HIV-1 infections in Nanjing from 2019 to 2021.

Shi H, Li X, Wang S, Dong X, Qiao M, Wu S BMC Infect Dis. 2024; 24(1):583.

PMID: 38867161 PMC: 11170874. DOI: 10.1186/s12879-024-09337-6.


References
1.
Woodring J, Kruszon-Moran D, Oster A, McQuillan G . Did CDC's 2006 revised HIV testing recommendations make a difference? Evaluation of HIV testing in the US household population, 2003-2010. J Acquir Immune Defic Syndr. 2014; 67(3):331-40. PMC: 7241860. DOI: 10.1097/QAI.0000000000000303. View

2.
Chkhartishvili N, Chokoshvili O, Bolokadze N, Tsintsadze M, Sharvadze L, Gabunia P . Late presentation of HIV infection in the country of Georgia: 2012-2015. PLoS One. 2017; 12(10):e0186835. PMC: 5662083. DOI: 10.1371/journal.pone.0186835. View

3.
Traynor S, Rosen-Metsch L, Feaster D . Missed Opportunities for HIV Testing Among STD Clinic Patients. J Community Health. 2018; 43(6):1128-1136. PMC: 6212336. DOI: 10.1007/s10900-018-0531-z. View

4.
Hu X, Liang B, Zhou C, Jiang J, Huang J, Ning C . HIV late presentation and advanced HIV disease among patients with newly diagnosed HIV/AIDS in Southwestern China: a large-scale cross-sectional study. AIDS Res Ther. 2019; 16(1):6. PMC: 6420760. DOI: 10.1186/s12981-019-0221-7. View

5.
Harklerode R, Waruiru W, Humwa F, Waruru A, Kellogg T, Muthoni L . Epidemiological profile of individuals diagnosed with HIV: results from the preliminary phase of case-based surveillance in Kenya. AIDS Care. 2019; 32(1):43-49. PMC: 6815685. DOI: 10.1080/09540121.2019.1612021. View